文献速递儿童神经与发育行为

家庭导航对自闭症风险儿童诊断确认的影响:DBPNet随机临床试验

Effect of Family Navigation on Diagnostic Ascertainment Among Children at Risk for Autism: A Randomized Clinical Trial From DBPNet.
PubMed 文献 · JAMA Pediatr · 2021-01-01

这项随机临床试验纳入249个在基层儿科筛查阳性的15-27月龄儿童家庭,比较家庭导航(FN)与常规照护管理(CCM)对诊断确认的影响。FN组在1年内达到诊断确认的可能性更高(85.7% vs 76.4%;未调整HR 1.39,95%CI 1.05-1.84),且效应受研究站点和族裔调节。

要点

  • 家庭导航可提高自闭症风险儿童1年内诊断确认率(85.7% vs 76.4%,HR 1.39)。
  • FN效果受站点和族裔调节,西班牙裔家庭中效应量更大。
  • 结果支持在低收入、少数族裔家庭中采用家庭导航促进诊断公平。

核心结论

  • 家庭导航提高了在基层被识别为自闭症风险儿童的诊断确认可能性。
  • FN效果因研究站点和族裔不同而存在差异,西班牙裔家庭中效应更强。

研究设计与样本

  • 随机临床试验纳入249个家庭,儿童年龄15-27月,筛查阳性提示可能自闭症。
  • 研究在3个城市11个城市基层儿科站点开展,数据收集于2015年2月24日至2018年11月5日。
  • 家庭随机分配至家庭导航(FN)或常规照护管理(CCM),主要分析基于意向性治疗。

主要发现

  • FN组108/126(85.7%)达到诊断确认,CCM组94/123(76.4%),未调整HR 1.39(95%CI 1.05-1.84)。
  • 西班牙裔家庭中FN组诊断确认率90.9%(30/33),CCM组53.3%(16/30)。

关键数值与推荐

  • 主要结局为从随机化到完成临床发育评估(确定自闭症或其他发育障碍诊断)的天数。
  • FN组由导航员提供社区外展以解决结构性障碍并支持参与推荐服务;CCM组由照护经理进行有限电话外展。
  • 干预从筛查阳性后开始,持续至诊断确认后100天。

临床怎么用

  • 在基层儿科对自闭症筛查阳性儿童,可考虑引入家庭导航以促进诊断评估的完成。
  • 实施家庭导航时需关注站点和族裔差异,可能需针对性调整策略。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early identification of autism spectrum disorder (ASD) is associated with improved cognitive and behavioral outcomes. Targeted strategies are needed to support equitable access to diagnostic services to ensure that children from low-income and racial/ethnic minority families receive the benefits of early ASD identification and treatment. OBJECTIVE: To test the efficacy of family navigation (FN), an individually tailored, culturally informed care management strategy, to increase the likelihood of achieving diagnostic ascertainment among young children at risk for ASD. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial of 249 families of children aged 15 to 27 months who had positive screening results for possible ASD was conducted in 11 urban primary care sites in 3 cities. Data collection occurred from February 24, 2015, through November 5, 2018. Statistical analysis was performed on an intent-to-treat basis from November 5, 2018, to July 27, 2020. INTERVENTIONS: Families were randomized to FN or conventional care management (CCM). Families receiving FN were assigned a navigator who conducted community-based outreach to families to address structural barriers to care and support engagement in recommended services. Families receiving CCM were assigned to a care manager, who did limited telephone outreach. Families received FN or CCM after positive initial screening results and for 100 days after diagnostic ascertainment. MAIN OUTCOMES AND MEASURES: The primary outcome, diagnostic ascertainment, was measured as the number of days from randomization to completion of the child's clinical developmental evaluation, when a diagnosis of ASD or other developmental disorder was determined. RESULTS: Among 250 families randomized, 249 were included in the primary analysis (174 boys [69.9%]; mean [SD] age, 22.0 [3.5] months; 205 [82.3%] publicly insured; 233 [93.6%] non-White). Children who received FN had a greater likelihood of reaching diagnostic ascertainment over the course of 1 year (FN, 108 of 126 [85.7%]; CCM, 94 of 123 [76.4%]; unadjusted hazard ratio [HR], 1.39 [95% CI, 1.05-1.84]). Site (Boston, New Haven, and Philadelphia) and ethnicity (Hispanic vs non-Hispanic) moderated the effect of FN (treatment × site interaction; P = .03; Boston: HR, 2.07 [95% CI, 1.31-3.26]; New Haven: HR, 1.91 [95% CI, 0.94-3.89]; and Philadelphia: HR, 0.91 [95% CI, 0.60-1.37]) (treatment × ethnicity interaction; P < .001; Hispanic families: HR, 2.81 [95% CI, 2.23-3.54] vs non-Hispanic families: HR, 1.49 [95% CI, 1.45-1.53]). The magnitude of FN's effect was significantly greater among Hispanic families than among non-Hispanic families (diagnostic ascertainment among Hispanic families: FN, 90.9% [30 of 33], and CCM, 53.3% [16 of 30]; vs non-Hispanic families: FN, 89.7% [35 of 39], and CCM, 77.5% [31 of 40]). CONCLUSIONS AND RELEVANCE: Family navigation improved the likelihood of diagnostic ascertainment among children from racial/ethnic minority, low-income families who were detected as at risk for ASD in primary care. Results suggest differential effects of FN by site and ethnicity. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02359084.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Feinberg E, Augustyn M, Broder-Fingert S, et al. Effect of Family Navigation on Diagnostic Ascertainment Among Children at Risk for Autism: A Randomized Clinical Trial From DBPNet. JAMA Pediatr. 2021. PMID: 33427861. doi:10.1001/jamapediatrics.2020.5218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。